L. Misery

Research interests

Publications

• Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2301333

• Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1908316

• Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

  Arthritis & Rheumatology · 2019 · https://doi.org/10.1002/art.41068

• Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

  Journal of the American Academy of Dermatology · 2019 · https://doi.org/10.1016/j.jaad.2019.02.053

• Definition of Sensitive Skin: An Expert Position Paper from the Special Interest Group on Sensitive Skin of the International Forum for the Study of Itch

  Acta Dermato Venereologica · 2016 · https://doi.org/10.2340/00015555-2397

• The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

  Journal of Investigative Dermatology · 2014 · https://doi.org/10.1038/jid.2014.530

• Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

  Allergy · 2011 · https://doi.org/10.1111/j.1398-9995.2011.02577.x

• Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency

  British Journal of Dermatology · 2011 · https://doi.org/10.1111/j.1365-2133.2011.10449.x

• Putative neuronal mechanisms of sensitive skin

  Experimental Dermatology · 2009 · https://doi.org/10.1111/j.1600-0625.2009.00861.x

Current projects

No projects listed.